Chronic Prostatitis & Prostate Cancer
Chronic prostatitis · Prostate cancer
Chronic prostatitis and prostate cancer: what the link is, and what it means for your PSA
Two questions bring men to this page. “My PSA is raised: is it the prostatitis or is it cancer?” and “If I have had chronic prostatitis for years, am I more likely to get prostate cancer?” The honest answers are: usually the prostatitis, and probably yes, somewhat. This page explains why chronic inflammation of the prostate is now taken seriously as a contributor to cancer, how it distorts PSA, and what a sensible man does about both.
Chronic prostatitis is not prostate cancer and does not turn into it overnight. But long-standing inflammation creates exactly the conditions in which cancer starts: repeated cell damage, constant cell replacement, and a chemical environment that suppresses the body’s defences. Pathologists find the lesions of chronic inflammation sitting next to prostate cancers far more often than chance would predict, and large studies find that men with a history of prostatitis are diagnosed with prostate cancer more often than men without. Treating chronic prostatitis properly, rather than living with it, is therefore not only about symptoms.
Prostatitis and PSA: the question most men actually have
Why inflammation raises PSA
PSA is a protein made by prostate cells. It leaks into the blood whenever the gland’s architecture is disturbed, and inflammation disturbs it constantly: swollen tissue, damaged ducts, leaking cells. A man with active chronic prostatitis can have a PSA of 5, 8 or more with no cancer anywhere in the gland. In men under 55 with a raised PSA, inflammation is by far the commonest explanation.
How to read a raised PSA
A raised PSA is a reason to examine and image the prostate properly, not a reason to biopsy it next week. Transrectal ultrasound with Doppler shows the inflammation directly; cultures find the organisms. When the inflammation is treated, PSA falls, often dramatically, and what remains is a far more honest number. A PSA that stays high after the inflammation has been cleared, or a suspicious area on imaging, is what should lead to a biopsy or MRI.
We follow PSA in every patient during treatment for chronic prostatitis. It is one of the objective markers that show the inflammation is receding.
How chronic inflammation prepares the ground for cancer
Inflammation that lasts for years is not a passive state. It produces a stream of signalling molecules (interleukins, growth factors, chemokines, enzymes such as cyclooxygenase-2) under the control of a master switch called NF-kB, the same switch that is active in most tumours and is triggered by carcinogens such as tobacco smoke and radiation. The damage happens through three mechanisms.
1. Oxidative damage to DNA
Inflammatory cells release oxidising molecules to kill microbes. In a chronically infected gland they never stop, and they damage the DNA of the prostate’s own cells year after year.
2. Constant cell replacement
Damaged cells are replaced, and every division is a chance for a damaged copy to survive. Tissue that is forced to regenerate continuously accumulates mutations.
3. A tumour-friendly environment
The inflammatory soup suppresses the programmed death of abnormal cells, stimulates new blood vessels and encourages cell proliferation: the three things a growing cancer needs.
The evidence linking chronic prostatitis and prostate cancer
Anatomy: where the two diseases meet
Prostate cancer and its precursor lesion (prostatic intraepithelial neoplasia, PIN) arise overwhelmingly in the peripheral zone of the gland, the same zone where chronic inflammation is concentrated, and in surgical and biopsy specimens the two are repeatedly found side by side. The peripheral zone is also anatomically vulnerable: its ducts open into the urethra at an angle that lets urine reflux back into the gland, and when years of inflammation have narrowed the urethra, that reflux becomes constant. Microbes and chemical irritation from refluxed urine then keep the inflammation going.
Epidemiology
Several large studies have found that men with a history of prostatitis are diagnosed with prostate cancer more often than men without one, with the risk reported at roughly one and a half to two and a half times higher depending on the analysis, and higher still in studies that included men whose prostatitis had never been diagnosed. Since chronic prostatitis is often silent, the true association is probably underestimated.
Laboratory and histology
Bacterial DNA is found in a meaningful share of prostate tissue removed for cancer, and inflammation is distributed unevenly through the gland, in foci, in specimens removed for both benign enlargement and cancer. In animals, induced chronic prostatitis produces atypical hyperplasia and severe dysplasia within months, with oxidative DNA damage and high proliferation markers. In human tissue, pathologists describe “proliferative inflammatory atrophy” (PIA): patches of inflamed, atrophic epithelium with a high proliferation rate that sit next to cancers and show transitions into high-grade PIN, an accepted precancerous lesion. PIA is the histological bridge between chronic prostatitis and prostate cancer.
Genetics and molecular biology
Prostate cancer runs in families, and some of the susceptibility genes identified (RNase L, MSR1, TLR4) govern how prostate cells respond to infection and inflammation. Shared exposure to an infectious agent can also mimic inheritance within a family. At the molecular level, the enzyme GSTP1, which detoxifies the oxidising products of inflammation, is strongly expressed in PIA and then silenced in PIN and in cancer. The current model is that chronic inflammation produces PIA, loss of GSTP1 leaves the cells defenceless against oxidative damage, and PIN and cancer follow.
Until the science says otherwise, the sensible position is the cautious one: chronic inflammation of the prostate should be found early and treated completely, not managed with intermittent antibiotics for a decade. Every man we treat has his gland measured and imaged repeatedly, his PSA followed, and his organisms cultured; a suspicious finding is investigated, and a PSA that stays high after the inflammation is gone is taken seriously. That is how you protect yourself from both diseases at once.
What to do if you have chronic prostatitis, or a raised PSA
- Get the inflammation diagnosed properly. Transrectal ultrasound with Doppler, uroflowmetry and cultures of prostatic fluid, not just a PSA and a urine test. How we do it.
- Treat it to the end. Inflammation that is only suppressed keeps doing damage. The Georgiadis Protocol aims at complete clearance, measured on ultrasound and cultures.
- Monitor with the right expectations. Expect PSA to fall as the gland recovers. Investigate what does not fall. Keep annual checks after 50, or earlier with a family history.
Raised PSA or years of prostatitis? Have it assessed.
Send us your PSA history, ultrasound reports and symptoms. We will tell you honestly whether the picture points to inflammation, what needs treating and what needs ruling out.
Frequently asked questions
Does chronic prostatitis cause prostate cancer?
Not directly, and most men with prostatitis never develop cancer. But long-standing inflammation damages DNA, forces constant cell replacement and creates a tumour-friendly environment, and the precancerous lesions of the prostate are found next to inflamed tissue far more often than chance would predict. Men with a history of prostatitis are diagnosed with prostate cancer more often. The link is real and is a good reason to treat chronic prostatitis completely.
Can prostatitis raise PSA, and by how much?
Yes, substantially. Active inflammation can push PSA to 5, 10 or higher with no cancer present, especially in younger men. PSA falls as the inflammation is treated. A raised PSA should lead to a proper examination and ultrasound first, and to a biopsy only if imaging is suspicious or the PSA stays high once the inflammation has cleared.
Should I have a biopsy because my PSA is raised?
Not as a first step if you have signs of prostatitis. A biopsy through an inflamed gland is more painful, more likely to cause infection, and often finds only inflammation. Treat and re-measure first; biopsy what remains suspicious. If imaging shows a suspicious lesion, that is investigated regardless.
Does treating prostatitis lower the risk of cancer?
No study has yet proven that treating prostatitis prevents prostate cancer. What is established is that chronic inflammation drives the precancerous changes, so removing it removes the driver. It also makes PSA meaningful again and makes any future cancer easier to detect early.
Can prostatitis be mistaken for cancer on ultrasound or MRI?
Yes, in both directions. Inflammation produces hypoechoic areas on ultrasound and signal changes on MRI that can look suspicious, and calcifications and fibrosis can hide small tumours. This is why the imaging should be read by someone who sees chronic prostatitis daily, and why we repeat it after treatment.
